Rani Therapeutics (RANI) CTO discloses initial stock, RSU and option holdings

robot
Abstract generation in progress

Rani Therapeutics’ Chief Technical Officer, Alireza Javadi, has reported his initial ownership of company securities through a Form 3 filing. The filing indicates direct holdings of 10,075 Class A common stock shares, which include restricted stock units (RSUs) vesting over several years, and various stock option awards with different exercise prices and vesting schedules. This report establishes his baseline equity position as an officer of the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin